Delivery Order SPE2DB25D3006-SPE2DB26FXHHC
- Not listed
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,144.01 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,054.25 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and runs through December 2026. The product...
- The Defense Logistics Agency awarded a $2,496.87 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18 units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 28, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,223.68 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count package). This firm fixed price delivery order, which represents a non-competitive set-aside award, is scheduled for completion by September 19, 2025, with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government,...
- The Defense Logistics Agency awarded a $1,748.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (8-count packaging). The delivery order, which concludes on September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.71 to AmerisourceBergen Drug Corp on August 11, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,285.89 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (8-count package) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18 count) with a contract ceiling value of $2,328.28. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $1,752.65 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under a larger procurement vehicle. No set-aside designation was used for this...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB26FXHHCDelivery Order
The Defense Logistics Agency awarded a $1,467.14 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for Yuvafem 10 mcg vaginal inserts (18 count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation and is scheduled for completion by October 29, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen holds a comprehensive $999.999 billion IDC with DLA Troop Support Medical through December 2026, which serves as the vehicle enabling delivery orders such as this one. The company supplies a broad range of pharmaceutical products and medical commodities to support military and veteran healthcare systems globally. This delivery order for Yuvafem, a vaginal hormone therapy product, exemplifies AmerisourceBergen's role in fulfilling specialized pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/28/25 |